Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Graft-versus-leukaemia

A J Barrett1, F van Rhee

  • 1Bone Marrow Transplant Unit, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 28092, USA.

Bailliere'S Clinical Haematology
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Elastase-Like Enzyme of Platelets.

Thrombosis and haemostasis·2019
Same author

Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.

Bone marrow transplantation·2017
Same author

High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring.

Bone marrow transplantation·2017
Same author

Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report.

Bone marrow transplantation·2016
Same author

Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system.

Bone marrow transplantation·2016
Same author

Rapid Remission Induction and Improved Disease Free Survival in Acute Myeloid Leukaemia Using Daunorubicin, ARA-C, and CCNU.

Leukemia & lymphoma·2016

Donor T-lymphocytes are crucial for graft-versus-leukaemia (GVL) effect in chronic myeloid leukaemia (CML) post-transplant. Research is defining GVL mechanisms and developing strategies to separate GVL from graft-versus-host disease.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • High relapse rates after T-cell depleted bone marrow transplantation (BMT) for chronic myeloid leukaemia (CML) highlight the need for effective graft-versus-leukaemia (GVL) strategies.
  • Donor lymphocyte transfusions demonstrate the potential of alloreacting T-lymphocytes in achieving remission for relapsed CML post-BMT.

Purpose of the Study:

  • To elucidate the mechanisms underlying the GVL response in chronic myeloid leukaemia.
  • To explore the relationship between GVL and graft-versus-host disease (GVHD).
  • To investigate the role of CD4+ T-cells in the GVL effect.

Main Methods:

  • Review of existing literature on BMT, CML, GVL, and GVHD.
  • Analysis of evidence implicating T-lymphocytes, particularly CD4+ T-cells, in GVL responses.

Related Experiment Videos

  • Examination of CML cell immunogenicity in the context of BMT outcomes.

    • Main Results:

    • Accumulating evidence suggests a central role for CD4+ T-cells in the GVL response.
    • The efficacy of GVL in curing CML post-BMT may be linked to the strong immunogenicity of CML cells.
    • GVL mechanisms and their connection to GVHD are increasingly understood.

    Conclusions:

    • The GVL effect mediated by donor T-lymphocytes is critical for managing chronic myeloid leukaemia after bone marrow transplantation.
    • Future research aims to develop novel transplant strategies that selectively enhance GVL while minimizing GVHD.
    • Identifying leukaemia-specific antigens and amplifying T-cell responses against them are key future directions.